Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD)

Gertrude van den Brink, Luuk Stapersma, Hanan El Marroun, Jens Henrichs, Eva M Szigethy, Elisabeth Mwj Utens, Johanna C Escher, Gertrude van den Brink, Luuk Stapersma, Hanan El Marroun, Jens Henrichs, Eva M Szigethy, Elisabeth Mwj Utens, Johanna C Escher

Abstract

Introduction: Adolescents with inflammatory bowel disease (IBD) show a higher prevalence of depression and anxiety, compared to youth with other chronic diseases. The inflammation-depression hypothesis might explain this association, and implies that treating depression can decrease intestinal inflammation and improve disease course. The present multicentre randomised controlled trial aims to test the effectiveness of an IBD-specific cognitive-behavioural therapy (CBT) protocol in reducing symptoms of subclinical depression and anxiety, while improving quality of life and disease course in adolescents with IBD.

Methods and analysis: Adolescents with IBD (10-20 years) from 7 hospitals undergo screening (online questionnaires) for symptoms of depression and anxiety. Those with elevated scores of depression (Child Depression Inventory (CDI) ≥13 or Beck Depression Inventory (BDI) II ≥14) and/or anxiety (Screen for Child Anxiety Related Disorders: boys ≥26, girls ≥30) receive a psychiatric interview. Patients meeting criteria for depressive/anxiety disorders are referred for psychotherapy outside the trial. Patients with elevated (subclinical) symptoms are randomly assigned to medical care-as-usual (CAU; n=50) or CAU plus IBD-specific CBT (n=50).

Main outcomes: (1) reduction in depressive and/or anxiety symptoms after 3 months and (2) sustained remission for 12 months.

Secondary outcomes: quality of life, psychosocial functioning, treatment adherence. In addition, we will assess inflammatory cytokines in peripheral blood mononuclear cells and whole blood RNA expression profiles. For analysis, multilevel linear models and generalised estimating equations will be used.

Ethics and dissemination: The Medical Ethics Committee of the Erasmus MC approved this study. If we prove that this CBT improves emotional well-being as well as disease course, implementation is recommended.

Trial registration number: NCT02265588.

Keywords: CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE; PSYCHOLOGICAL STRESS; PSYCHOTHERAPY; ULCERATIVE COLITIS.

Figures

Figure 1
Figure 1
Flow chart study design (ADIS-C/P, Anxiety Disorders Interview Schedule—Child and Parent Version; ADRS, Adolescent Depression Rating Scale; BDI-II, Beck Depression Inventory—Second Edition; CDI, Child Depression Inventory; CDRS-R, Child Depression Rating Scale—Revised; PARS, Pediatric Anxiety Rating Scale; SCARED, Screen for Child Anxiety Related Emotional Disorders).

References

    1. Baumgart DC, Bernstein CN, Abbas Z, et al. . IBD around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010—Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis 2011;17:639–44.
    1. Greenley RN, Hommel KA, Nebel J, et al. . A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol 2010;35:857–69.
    1. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 2004;18:509–23.
    1. Rabizadeh S, Dubinsky M. Update in pediatric inflammatory bowel disease. Rheum Dis Clin North Am 2013;39:789–99.
    1. Engelmann G, Erhard D, Petersen M, et al. . Health-related quality of life in adolescents with inflammatory bowel disease depends on disease activity and psychiatric comorbidity. Child Psychiatry Hum Dev 2015;46:300–7.
    1. Lynch T, Spence D. A qualitative study of youth living with Crohn disease. Gastroenterol Nurs 2008;31:224–30; quiz 31–2
    1. Kilroy S, Nolan E, Sarma KM. Quality of life and level of anxiety in youths with inflammatory bowel disease in Ireland. J Pediatr Gastroenterol Nutr 2011;53:275–9.
    1. Ross SC, Strachan J, Russell RK, et al. . Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;53:480–8.
    1. Karwowski CA, Keljo D, Szigethy E. Strategies to improve quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1755–64.
    1. Mackner LM, Greenley RN, Szigethy E, et al. . Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2013;56:449–58.
    1. Szigethy E, Craig AE, Iobst EA, et al. . Profile of depression in adolescents with inflammatory bowel disease: implications for treatment. Inflamm Bowel Dis 2009;15:69–74.
    1. Szigethy E, McLafferty L, Goyal A. Inflammatory bowel disease. Pediatr Clin North Am 2011;58:903–20, x–xi
    1. Burke P, Meyer V, Kocoshis S, et al. . Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989;28:948–51.
    1. Burke PM, Neigut D, Kocoshis S, et al. . Correlates of depression in new onset pediatric inflammatory bowel disease. Child Psychiatry Hum Dev 1994;24:275–83.
    1. Clark JG, Srinath AI, Youk AO, et al. . Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr 2014;58:569–73.
    1. Reigada LC, Bruzzese JM, Benkov KJ, et al. . Illness-specific anxiety: implications for functioning and utilization of medical services in adolescents with inflammatory bowel disease. J Spec Pediatr Nurs 2011;16:207–15.
    1. Szigethy E, Kenney E, Carpenter J, et al. . Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry 2007;46:1290–8.
    1. Szigethy E, Levy-Warren A, Whitton S, et al. . Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr 2004;39:395–403.
    1. Reigada LC, Hoogendoorn CJ, Walsh LC, et al. . Anxiety symptoms and disease severity in children and adolescents with Crohn disease. J Pediatr Gastroenterol Nutr 2015;60:30–5.
    1. Axelson DA, Birmaher B. Relation between anxiety and depressive disorders in childhood and adolescence. Depress Anxiety 2001;14:67–78.
    1. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. . Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis 2007;13:225–34.
    1. Copeland WE, Shanahan L, Costello EJ, et al. . Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry 2009;66:764–72.
    1. Thompson RD, Craig A, Crawford EA, et al. . Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms. J Clin Psychol Med Settings 2012;19:329–37.
    1. Loftus EV Jr, Guerin A, Yu AP, et al. . Increased risks of developing anxiety and depression in young patients with Crohn's disease. Am J Gastroenterol 2011;106:1670–7.
    1. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013;144:36–49.
    1. Goodhand JR, Wahed M, Mawdsley JE, et al. . Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis 2012;18:2301–9.
    1. Bennebroek Evertsz F, Thijssens NA, Stokkers PC, et al. . Do inflammatory bowel disease patients with anxiety and depressive symptoms receive the care they need? J Crohns Colitis 2012;6:68–76.
    1. Panara AJ, Yarur AJ, Rieders B, et al. . The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment Pharm Ther 2014;39:802–10.
    1. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009;15:1105–18.
    1. Mittermaier C, Dejaco C, Waldhoer T, et al. . Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004;66:79–84.
    1. Nahon S, Lahmek P, Durance C, et al. . Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis 2012;18:2086–91.
    1. Keethy D, Mrakotsky C, Szigethy E. Pediatric inflammatory bowel disease and depression: treatment implications. Curr Opin Pediatr 2014;26:561–7.
    1. Simren M, Axelsson J, Gillberg R, et al. . Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389–96.
    1. Engstrom I. Inflammatory bowel disease in children and adolescents: mental health and family functioning. J Pediatr Gastroenterol Nutr 1999;28:S28–33.
    1. Gray WN, Graef DM, Schuman SS, et al. . Parenting stress in pediatric IBD: relations with child psychopathology, family functioning, and disease severity. J Dev Behav Pediatr 2013;34:237–44.
    1. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006;12:697–707.
    1. Mackner LM, Crandall WV. Psychological factors affecting pediatric inflammatory bowel disease. Curr Opin Pediatr 2007;19:548–52.
    1. Szigethy EM, Youk AO, Benhayon D, et al. . Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;58:574–81.
    1. Reed-Knight B, Lobato D, Hagin S, et al. . Depressive symptoms in youth with inflammatory bowel disease compared with a community sample. Inflamm Bowel Dis 2014;20:614–21.
    1. Bernstein CN, Singh S, Graff LA, et al. . A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 2010;105:1994–2002.
    1. Bitton A, Dobkin PL, Edwardes MD, et al. . Predicting relapse in Crohn's disease: a biopsychosocial model. Gut 2008;57:1386–92.
    1. Bitton A, Sewitch MJ, Peppercorn MA, et al. . Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol 2003;98:2203–8.
    1. Levenstein S, Prantera C, Varvo V, et al. . Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000;95:1213–20.
    1. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005;54:1481–91.
    1. Srinath AI, Goyal A, Zimmerman LA, et al. . Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis 2014;20:1329–40.
    1. Ryan JL, Mellon MW, Junger KW, et al. . The clinical utility of health-related quality of life screening in a pediatric inflammatory bowel disease clinic. Inflamm Bowel Dis 2013;19:2666–72.
    1. Gray WN, Denson LA, Baldassano RN, et al. . Treatment adherence in adolescents with inflammatory bowel disease: the collective impact of barriers to adherence and anxiety/depressive symptoms. J Pediatr Psychol 2012;37:282–91.
    1. O'Donovan A. Inflammation and depression: unraveling the complex interplay in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;58:541–2.
    1. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24–31.
    1. Mawdsley JE, Rampton DS. The role of psychological stress in inflammatory bowel disease. Neuroimmunomodulation 2006;13:327–36.
    1. Reber SO. Stress and animal models of inflammatory bowel disease—an update on the role of the hypothalamo-pituitary-adrenal axis. Psychoneuroendocrinology 2012;37:1–19.
    1. Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 2014;140:774–815.
    1. Penninx BW, Milaneschi Y, Lamers F, et al. . Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013;11:129
    1. Schmidt HD, Shelton RC, Duman RS. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 2011;36:2375–94.
    1. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171–86.
    1. Dowlati Y, Herrmann N, Swardfager W, et al. . A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446–57.
    1. Vogelzangs N, Beekman AT, de Jonge P, et al. . Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry 2013;3:e249
    1. Hou R, Baldwin DS. A neuroimmunological perspective on anxiety disorders. Hum Psychopharmacol 2012;27:6–14.
    1. Salim S, Chugh G, Asghar M. Inflammation in anxiety. Adv Protein Chem Struct Biol 2012;88:1–25.
    1. Hoge EA, Brandstetter K, Moshier S, et al. . Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009;26:447–55.
    1. Szigethy E, Weisz JR, Findling RL. Cognitive-behavior therapy for children and adolescents. Arlington: American Psychiatric Publishing, 2012:331–78.
    1. Thompson RD, Delaney P, Flores I, et al. . Cognitive-behavioral therapy for children with comorbid physical illness. Child Adolesc Psychiatr Clin N Am 2011;20:329–48.
    1. Szigethy E, Whitton SW, Levy-Warren A, et al. . Cognitive-behavioral therapy for depression in adolescents with inflammatory bowel disease: a pilot study. J Am Acad Child Adolesc Psychiatry 2004;43:1469–77.
    1. Szigethy E, Bujoreanu SI, Youk AO, et al. . Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 2014;53:726–35.
    1. Reigada LC, Benkov KJ, Bruzzese JM, et al. . Integrating illness concerns into cognitive behavioral therapy for children and adolescents with inflammatory bowel disease and co-occurring anxiety. J Spec Pediatr Nurs 2013;18:133–43.
    1. Timbremont B, Brat C, Roelofs J. Handleiding children's depression inventory (herziene versie). Amsterdam, NL: Pearson, 2008.
    1. van der Does AJW. BDI-II-NL. Handleiding. De Nederlandse versie van de Beck Depression Inventory. Lisse, NL: Harcourt Test Publishers, 2002.
    1. Muris P, Bodden D, Hale W,, et al. . Vragenlijst over angst en bang zijn bij kinderen en adolescenten. Handleiding bij gereviseerde Nederlandse versie van de Screen for Child Anxiety Related Disorders. Amsterdam, NL: Boom, 2007.
    1. Bodden DH, Bogels SM, Muris P. The diagnostic utility of the Screen for Child Anxiety Related Emotional Disorders-71 (SCARED-71). Behav Res Ther 2009;47:418–25.
    1. Siebelink BM, Treffers PDA. Anxiety disorders interview schedule for DSM-IV-child version, ADIS-C Handleiding. Amsterdam: Harcourt Test Publishers, 2001.
    1. Silverman WK, Albano AM. Anxiety disorders interview schedule for DSM-IV child version, child interview schedule. San Antonio: The Psychological Corporation, 1996.
    1. Poznanski EO, Mokros H. Children's depression rating scale revised (CDRS-R). Los Angeles: Western Psychological Services, 1996.
    1. Revah-Levy A, Birmaher B, Gasquet I, et al. . The Adolescent Depression Rating Scale (ADRS): a validation study. BMC Psychiatry 2007;7:2
    1. No authors listed The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 2002;41:1061–9.
    1. Ginsburg GS, Keeton CP, Drazdowski TK, et al. . The utility of clinicians ratings of anxiety using the Pediatric Anxiety Rating Scale (PARS). Child Youth Care For 2011;40:93–105.
    1. Vogels T, Verrips GHW, Koopman HM, et al. . Child Quality of Life Questionnaire (TACQOL). Manual parent and child form. Leiden, NL: LUMC-TNO, 1999.
    1. Bruil J, Fekkes M, Vogels T, et al. . TAAQOL Manual. Leiden, NL: Leiden Center for Child Health and Pediatrics LUMC-TNO, 2004.
    1. Loonen HJ, Grootenhuis MA, Last BF, et al. . Measuring quality of life in children with inflammatory bowel disease: the impact-II (NL). Qual Life Res 2002;11:47–56.
    1. Liber JM, Van Lang NDJ, Treffers PDA. Confirmatory factor analysis of the Dutch version of the Social Skills Rating System: Curium, Academic Center for Child and Adolescent Psychiatry. LUMC, 2006.
    1. Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms & profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families, 2001.
    1. Achenbach TM, Rescorla LA. Manual for the ASEBA Adult Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families, 2003.
    1. Utens EMWJ, van Rijen EHM, Erdman RAM, et al. . Rotterdam's Kwaliteit van Leven Interview: Erasmus MC Rotterdam, Netherlands. Department of Child and Adolescent Psychiatry and Psychology, 2000.
    1. Broadbent E, Petrie KJ, Main J, et al. . The brief illness perception questionnaire. J Psychosom Res 2006;60:631–7.
    1. Garnefski N, Kraaij V, Spinhoven P. CERQ: Manual for the use of the cognitive emotion regulation questionnaire. A questionnaire for measuring cognitive coping strategies. Leiderdorp, NL: Datec V.O.F., 2007.
    1. Owens JA, Spirito A, McGuinn M, et al. . Sleep habits and sleep disturbance in elementary school-aged children. J Dev Behav Pediatr 2000;21:27–36.
    1. Beurs E, Van Dyck R, Marquenie LA, et al. . De DASS: een vragenlijst voor het meten van depressie, angst en stress. Gedragstherapie 2001;34:35–53.
    1. Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer 2008;113:870–8.
    1. Epstein NB, Baldwin LM, Bishop DS. The McMaster family assessment device. J Marital Fam Ther 1983;9:171–80.
    1. Weisz JR, Thurber CA, Sweeney L, et al. . Brief treatment of mild-to-moderate child depression using primary and secondary control enhancement training. J Consult Clin Psychol 1997;65:703–7.
    1. Hyams JS, Ferry GD, Mandel FS, et al. . Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439–47.
    1. Turner D, Griffiths AM, Walters TD, et al. . Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis 2012;18:55–62.
    1. Turner D, Otley AR, Mack D, et al. . Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007;133:423–32.
    1. Hyams J, Crandall W, Kugathasan S, et al. . Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007;132:863–73; quiz 1165–6
    1. Utens EM, Verhulst FC, Duivenvoorden HJ, et al. . Prediction of behavioural and emotional problems in children and adolescents with operated congenital heart disease. Eur Heart J 1998;19:801–7.
    1. Klein JB, Jacobs RH, Reinecke MA. Cognitive-behavioral therapy for adolescent depression: a meta-analytic investigation of changes in effect-size estimates. J Am Acad Child Adolesc Psychiatry 2007;46:1403–13.
    1. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006;132:132–49.
    1. In-Albon T, Schneider S. Psychotherapy of childhood anxiety disorders: a meta-analysis. Psychother Psychosom 2007;76:15–24.
    1. Reynolds S, Wilson C, Austin J, et al. . Effects of psychotherapy for anxiety in children and adolescents: a meta-analytic review. Clin Psychol Rev 2012;32:251–62.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren